Author: toxlaw

Femoral blood collected at autopsy cannot automatically be treated as the concentration present before death. In a historical series, Hilberg and colleagues found substantial differences between earlier serum and later femoral blood for tricyclic antidepressants. Peripheral sampling helped limit some problems associated with heart blood, but did not eliminate postmortem change.

What the study actually compared

The 1999 paper described ten human cases overall. Eight involved comparisons with ante- or perimortem serum; two additional cases involved early postmortem blood. The tricyclic analysis of femoral blood pooled 11 drug or metabolite observations from six people, not 11 independent decedents. The compounds included amitriptyline, nortriptyline, imipramine and desipramine.

Autopsies in the overall series occurred at a median of two days after death, with a reported range of one to seven days. Femoral blood was obtained through a groin incision while the lower limb was elevated, drained into a clean scoop, and transferred to tubes containing potassium fluoride. The collectors tried to avoid blood from the iliac veins above. Samples were stored at −20°C until analysis. Heart specimens, where available, came from an unspecified chamber.

A higher postmortem result was common, but not universal

The pooled median femoral-blood-to-earlier-serum ratio for tricyclic compounds was 3.3, with a reported 95% reference range of 1.1–6.0. That reference range describes the pooled observations; it is not a validated prediction interval for any new individual.

In one amitriptyline case, serum measured 2.0 μmol/L and femoral blood collected at autopsy two days after death measured 12 μmol/L, a ratio of 6.0. Nortriptyline in the same case changed from 1.3 to 6.0 μmol/L. In another case, nortriptyline was 2.0 μmol/L in perimortem serum and 1.8 μmol/L in femoral blood the following day, a ratio of 0.9. The exception matters: the study did not establish an inevitable increase of a fixed size.

The denominator was serum, not earlier femoral whole blood

A ratio across both time and matrix cannot isolate redistribution alone. The authors discussed differences in drug partitioning between serum or plasma and whole blood, as well as resuscitation and sampling technique. They considered matrix partitioning insufficient to explain the full tricyclic differences, but that does not turn every observed ratio into a pure measure of postmortem movement.

Quantitative analysis used HPLC with ultraviolet detection. The described method had a 0.2 μmol/L detection limit, calibration from 0.2–10 μmol/L, recovery above 80% at 1 and 10 μmol/L, and within-run precision below 10% CV. Some case concentrations exceeded the stated calibration range; the paper does not explain every such result’s dilution or extended-range procedure. A modern case review should obtain those laboratory details rather than presume them.

What this evidence supports in a death investigation

The series supports caution when an autopsy concentration is compared directly with a therapeutic serum range. It does not supply a universal divisor of 3.3, prove an administered dose, or establish cause of death from the concentration alone. Treatment, elapsed time, other drugs, pathology and the original analytical records remain material.

For the distinct problem of comparing two postmortem sites, see central-to-peripheral blood ratios. A site ratio and a postmortem-to-antemortem comparison answer different questions.

Primary source

Hilberg T, Rogde S, Mørland J. Postmortem Drug Redistribution—Human Cases Related to Results in Experimental Animals. Journal of Forensic Sciences. 1999;44(1):3–9. doi:10.1520/JFS14404J.

Responding more slowly does not necessarily mean that handling conflict is selectively impaired. A 2019 study of adults after prolonged methamphetamine abstinence found slower overall responses alongside several preserved task effects. The distinction matters when a broad impairment label is applied to a specific cognitive operation.

A selected matched sample

Bensmann and colleagues initially recruited 32 former methamphetamine consumers and 32 individually matched controls. Eight former consumers were excluded, including four who did not perform above chance; the corresponding matched controls were also removed. The final sample contained 24 participants in each group.

The former-consumer group reported approximately 7.2 years of prior use and an average 31.9 months of abstinence, ranging from 1.5 to 120 months. These were retrospective histories, not a uniform abstinence interval. The sample partly overlapped with an earlier study and should not be counted as an entirely independent cohort from that work.

What does a flanker task measure?

Participants selected responses while surrounding information either supported or conflicted with the target. The flanker effect compares conflicting with matching trials. The Gratton effect examines how the preceding trial’s conflict changes the current conflict effect.

The investigators also measured post-error slowing: a change in response speed after a mistake. General response speed, conflict interference, adjustment after conflict and adjustment after errors were therefore separate outcomes.

Which result differed between groups?

Overall responses were slower in former consumers: approximately 369 milliseconds versus 351 milliseconds in controls, with p = 0.028. This was a general group effect, not evidence of a uniquely enlarged conflict cost.

The groups did not differ significantly in overall accuracy, the size of the flanker effect, the Gratton effect or post-error slowing. Complementary Bayesian analyses generally supported the absence of the tested group differences, rather than relying only on nonsignificant conventional tests.

Bayesian support remains conditional on the models and assumptions used. It is not proof that all possible differences are zero, nor a demonstration of equal real-world functioning across every domain.

Does this prove cognitive recovery?

No. The study did not follow the same participants from active use through prolonged abstinence. People who achieved longer abstinence and volunteered for research may differ from people who did not. The findings could reflect preserved function, recovery, selection or a combination.

Excluding participants who did not perform above chance also limits generalization to people with greater task difficulty. The reported null comparisons describe the retained sample; they should not be used to erase the excluded participants’ performance problems.

Why not compare short and long abstinence directly?

The authors explored a median split of the former-consumer group, but each subgroup contained only 12 people. They cautioned against strong conclusions because of limited power. That exploratory comparison cannot establish a minimum abstinence duration required for preserved control.

The study supports a precise statement: selected adults with prolonged abstinence showed general slowing without demonstrably larger conflict-related or post-error costs on this task. It does not establish that all cognition was unaffected, that past methamphetamine use caused the slowing, or that a particular individual was fit or unfit to drive.

Historical primary source

Bensmann W, Ernst J, Rädle M, Opitz A, Beste C, Stock AK. Methamphetamine Users Show No Behavioral Deficits in Response Selection After Protracted Abstinence. Frontiers in Psychiatry. 2019;10:823. doi:10.3389/fpsyt.2019.00823.

A single average brain response can conceal changes during a task. In a 2022 methamphetamine study, researchers analyzed successive time windows to examine whether responses to drug cues and demands to withhold actions changed over the session.

Who contributed usable imaging?

Jafakesh and colleagues recruited 62 treatment-seeking men with methamphetamine dependence from centers in Tehran. Nine were excluded from imaging analyses because of excessive movement, leaving 53. Participants were 20 to 40 years old and required at least one week of abstinence from substances other than nicotine, based on history and urine screening.

There was no healthy comparison group. The design therefore could describe temporal patterns within this selected sample, but could not determine whether those patterns were specific to methamphetamine dependence.

The task combined cues and action demands

During a mixed Go/NoGo task, participants responded to Go stimuli and withheld responses to NoGo stimuli. Drug-related and neutral pictures allowed the investigators to examine cue responses, inhibition responses and their interaction. The broader task also contained negative emotional material.

The analysis divided the imaging data into three temporal windows and used mixed-effects models. A change over windows was a within-session imaging result, not evidence that brain function changed over weeks of treatment.

What changed over time?

Drug-versus-neutral cue responses declined in selected regions, including temporal areas, amygdala, hippocampus and precuneus. The authors interpreted these declining contrasts as neural habituation.

Inhibition-related signals increased over time in several regions associated with the frontoparietal network. For the interaction involving inhibition during methamphetamine cues, dynamic activity appeared in parahippocampal regions and right precuneus.

These results distinguish contrasts, regions and time. They do not show that all brain activity declined or that all inhibitory processes improved. An increasing signal may reflect changing recruitment, effort, strategy or other processes, rather than a direct measure of better control.

Did craving decline as the scan progressed?

The study measured craving before and after scanning, but did not repeatedly measure it across the task’s temporal windows. Consequently, the investigators could not directly test whether a declining regional cue response tracked a simultaneous decline in reported craving.

Calling the imaging pattern “habituation” does not establish that a participant stopped wanting methamphetamine. Nor does the coexistence of increasing inhibition-related activity prove that stronger control caused declining cue responses.

Why is the result exploratory?

All participants were men seeking treatment, and there was no comparison sample or randomized cue-exposure treatment. Salient pictures could carry over into later blocks, making it difficult to isolate each condition. Splitting data into windows also reduces statistical power and introduces analytic choices requiring replication.

Reported associations between temporal patterns and clinical or behavioral measures are useful hypotheses. They do not validate an individual biomarker, predict relapse prospectively or establish that repeated cue exposure is an effective intervention.

The study’s practical contribution is to caution against treating a session average as a fixed trait. Timing within the task can matter, while the connection between neural change and meaningful clinical change remains unproven.

Primary scientific source

Jafakesh S, Sangchooli A, Aarabi A, et al. Temporally dynamic neural correlates of drug cue reactivity, response inhibition, and methamphetamine-related response inhibition in people with methamphetamine use disorder. Scientific Reports. 2022;12:3567. doi:10.1038/s41598-022-05619-8.

A choice that is difficult for one person may be easy for another. Comparing brain responses to identical monetary offers can therefore confound group membership with subjective difficulty. A 2007 methamphetamine imaging study addressed this problem by tailoring choices to each participant’s preferences.

Establishing individual reward preferences

Monterosso and colleagues studied 12 methamphetamine-dependent adults and 17 comparison adults. They first used hypothetical monetary choices outside the scanner to estimate how each participant discounted delayed rewards. Larger discounting meant a greater willingness to accept less money immediately instead of more money later.

The methamphetamine group showed greater discounting. Its geometric mean discounting parameter was 0.045 versus 0.013 in controls. Those are model parameters, not drug concentrations or a percentage of participants judged impaired. Response times in the initial assessment did not differ significantly.

The dependent participants stayed in a research center for five to seven days of abstinence before testing, verified with urine testing. Prior use varied in amount and route. The study did not administer a fixed methamphetamine dose or establish a concentration-response threshold.

How were easy and hard choices constructed?

The researchers used each person’s estimated preferences to generate three scanner conditions. Hard choices offered immediate and delayed alternatives of approximately equal subjective value. Easy choices offered alternatives with markedly different estimated values. A no-choice condition presented only one option.

This design matters because a greater preference for immediate money does not itself mean that every immediate-versus-delayed choice is more difficult. Personalizing value helped compare the demands of deciding, rather than merely comparing identical dollar amounts.

What did the imaging show?

Across groups, hard choices versus no-choice trials recruited several frontal and parietal regions. Within those task-defined regions, the hard-versus-easy contrast differed between groups in the left dorsolateral prefrontal cortex and right intraparietal sulcus.

Controls showed less recruitment for easy than hard choices. The methamphetamine group generally showed less differentiation between the two difficulty levels. Similar patterns in other tested clusters did not reach significance and should not be described as confirmed differences everywhere.

Did that pattern explain greater discounting?

No significant relationship was found between the hard-versus-easy activation difference and the degree of delay discounting. The imaging group difference therefore did not establish the proposed explanation for the behavioral group difference.

A separate relationship appeared between signal in a ventrolateral prefrontal region and discounting for the hard-versus-no-choice contrast. That result concerns a different comparison and cannot replace the null finding for difficulty-related differentiation.

The investigators also did not detect a significant imaging difference between hard trials on which participants selected the larger delayed reward and those on which they selected the smaller immediate reward. Neither preference was identified by a validated neural signature.

Limits of a small historical study

The sample included only 29 people, with smoking and prior other-drug exposure relevant to interpretation. Monetary outcomes were hypothetical, and the observational design did not establish whether group differences preceded or followed methamphetamine use.

The useful contribution is the method: subjective difficulty deserves explicit control. The study does not validate a brain scan for an individual’s impulsivity, functional incapacity or driving impairment.

Historical primary source

Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED. Frontoparietal Cortical Activity of Methamphetamine-Dependent and Comparison Subjects Performing a Delay Discounting Task. Human Brain Mapping. 2007;28:383–393. doi:10.1002/hbm.20281.

Two groups can make similar average choices on a laboratory task while differing in earnings or task-related brain activity. A 2014 methamphetamine study illustrates why these outcomes must be reported separately.

Task imaging and resting imaging had different denominators

Kohno and colleagues recruited 26 methamphetamine-dependent adults and 27 controls. One methamphetamine participant was excluded for excessive head motion, leaving 25 and 27 for the main imaging sample. Only 15 methamphetamine participants and 18 controls underwent the resting-state scan: 33 people, rather than all 52.

Participants were not seeking treatment. The methamphetamine group was studied after several days of abstinence, with urine testing used to verify abstinence from the specified substances. This was a case-control imaging study, not an administered-dose experiment or a test of acute intoxication.

How did the balloon task work?

Participants chose whether to pump a virtual balloon, increasing potential earnings by $0.25 per pump, or cash out. An explosion lost that balloon’s accumulated earnings. Colored balloons had different explosion contingencies, and control balloons provided a comparison condition.

Pump number indexed both increasing risk and increasing potential reward. The task therefore did not isolate one psychological process perfectly: evaluation, reward anticipation and choice could contribute to the measured signal.

What did the participants actually do?

The investigators found no significant group effect on pumping and no significant difference in average pumps before cashing out. Mean cash-out pump counts were 2.74 in the methamphetamine group and 2.84 in controls; the reported comparison was p = 0.180.

Controls nevertheless earned more overall: approximately $33.33 versus $30.15, with a significant comparison. It would be inaccurate to summarize this as uniformly greater pumping or greater willingness to take risk in the methamphetamine group.

Brain-response slopes differed

During pumping, right dorsolateral prefrontal activation increased more strongly with pump number in controls. Ventral-striatal modulation was greater in the methamphetamine group in the region-of-interest analysis. The prefrontal difference also appeared in the whole-brain analysis; no other significant whole-brain group differences or mean-activation differences were found in that comparison.

A steeper activation slope is distinct from a higher average signal. It describes how activity changes as the task changes, not a direct measurement of decision quality or brain injury.

Connectivity does not establish direction of control

The smaller resting-state sample showed greater midbrain connectivity with several regions in the methamphetamine group. Right dorsolateral prefrontal resting connectivity did not show a group difference.

Resting functional connectivity measures correlated signal variation. The authors expressly cautioned that it does not establish direction: a correlation between regions cannot by itself demonstrate that one region failed to control another.

Other limitations include small samples, differences in marijuana histories, overlapping control participants with earlier research, and the risk of inferring a mental process solely from an activated region. The findings are group-level associations, not an individual test of dangerousness, driving impairment or causal drug injury.

Historical primary source

Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED. Risky Decision-making: Prefrontal Function and Mesocorticolimbic Resting-state Connectivity in Methamphetamine Users. JAMA Psychiatry. 2014;71(7):812–820. doi:10.1001/jamapsychiatry.2014.399.

Everyday difficulties in a person with a methamphetamine-use history cannot automatically be attributed to that exposure. Childhood-onset conditions may contribute to both the history and later functioning. A 2013 study examined ADHD as one such factor.

A 755-person retrospective study

Obermeit and colleagues examined 400 participants with methamphetamine-use disorders within 18 months of evaluation and 355 comparison participants without that history. Participants came from methamphetamine and HIV research cohorts recruited primarily through local HIV and drug-treatment clinics.

ADHD diagnoses were established through a structured interview using DSM-IV criteria, including childhood symptoms between ages six and ten. Current ADHD required full criteria within the preceding year; lifetime ADHD referred to criteria met at any time.

Participants were required to have negative urine toxicology for illicit substances other than marijuana on the testing day. That screening criterion does not establish a uniform duration of methamphetamine abstinence or a concentration associated with functioning.

What did the prevalence comparison show?

Lifetime ADHD occurred in approximately 20.8% of the methamphetamine group and 6.2% of comparison participants. Adjustment for selected background differences still showed an association between methamphetamine-group status and ADHD.

The pattern differed by subtype. Combined and hyperactive subtypes were more frequent in the methamphetamine group, while the inattentive subtype comparison was not significant. Persistence of childhood combined-type ADHD into adulthood also differed; persistence comparisons for the other subtypes did not.

These are sample-specific prevalence findings, not estimates for every person who has used methamphetamine. Recruitment through clinical and research cohorts limits generalization.

Which everyday outcomes were associated with ADHD?

Within the methamphetamine group, lifetime ADHD remained associated with more cognitive symptoms, greater dependence in instrumental daily activities and unemployment in adjusted models. The models considered education and reading ability, age, depression, neurocognitive impairment and other substance-use histories.

Daily functioning was assessed predominantly through self-report. Employment included full- or part-time work; it should not be recast as an exclusively full-time employment outcome. The study’s statistical use of “predictor” refers to regression association, not a prospectively validated prediction of future disability.

What does the study leave unresolved?

Retrospective diagnosis and self-report can introduce recall or reporting bias. The analysis did not determine whether ADHD increased susceptibility to methamphetamine-use problems, whether use influenced persistence of childhood symptoms, or whether shared factors contributed to both.

It did not demonstrate that methamphetamine caused ADHD. Nor did it test whether treating ADHD would improve the reported functional outcomes. Those are separate causal and intervention questions.

For an expert reviewing an individual matter, the study supports examining developmental history alongside exposure history, objective testing and functional records. A positive drug result cannot establish the source of a longstanding organizational difficulty, and an ADHD diagnosis cannot itself resolve legal capacity, credibility or driving impairment.

Historical primary source

Obermeit LC, Cattie JE, Bolden KA, et al. Attention-Deficit/Hyperactivity Disorder Among Chronic Methamphetamine Users: Frequency, Persistence, and Adverse Effects on Everyday Functioning. Addictive Behaviors. 2013;38(12):2874–2878. doi:10.1016/j.addbeh.2013.08.010.

Executive functioning is an umbrella description, not a single measurable ability. A 2009 comparison of alcohol-, cocaine- and methamphetamine-dependent adults found different patterns across decision-making, working memory, switching and response inhibition. Its null results limit a claim of uniformly impaired executive control.

The four participant groups

Van der Plas and colleagues enrolled 33 alcohol-dependent participants, 27 cocaine-dependent participants, 38 methamphetamine-dependent participants and 36 healthy comparison participants: 134 people overall. The methamphetamine group included 25 women; the other groups also included both men and women.

Substance-dependent participants were tested near discharge from treatment after at least 15 days of abstinence. Urine screening and breath alcohol testing were performed before assessment. This was an observational comparison of existing groups, not a controlled administration study. Primary drug-of-choice categories do not mean that each group had an exclusive lifetime exposure to one substance.

Decision-making differed from stopping

On the Iowa Gambling Task, cocaine and methamphetamine groups developed less advantageous choices than controls across successive blocks. Alcohol-group differences were less consistent across the task, appearing in later blocks. Comparisons between the substance-dependent groups did not establish significant differences in their learning rates.

By contrast, the study did not establish a group difference in stop-signal response inhibition. This null finding must accompany the decision-making findings: performance on a virtual card-choice task cannot be substituted for the ability to cancel an initiated response.

The stop-signal analysis also excluded 30 participants who failed to inhibit on more than 80% of stop trials. Results therefore apply to the analyzed subset, not automatically to all 134 recruits. Exclusion can change the composition of the sample whose stopping time can be estimated.

Working memory and switching were more nuanced

The methamphetamine and cocaine groups performed less accurately on a visuospatial working-memory task than controls. The group difference did not grow significantly with increased memory load. Methamphetamine participants also made more errors than the other substance-dependent groups on this measure.

On the switching task, methamphetamine and cocaine participants were slower than controls, but the additional cost of switching did not differ significantly by group. General slowing is therefore distinct from a selectively increased switching cost.

Wisconsin Card Sorting perseverative errors did not show significant group or sex effects after adjustment. A positive result on one flexibility measure does not authorize labeling every flexibility outcome abnormal.

How strong was the sex finding?

The paper discussed poorer gambling performance among women in the stimulant groups. However, the task-block-by-group-by-sex interaction was a trend, reported as p < 0.055. That qualification matters: it should not become a confirmed, universal claim that methamphetamine affects women more severely.

Small subgroups, varying task denominators, multiple comparisons and observational selection all constrain interpretation. Adjustment for age and education does not establish that substance exposure caused the differences or remove every premorbid influence.

The practical lesson is to name the exact domain and outcome. This historical study supports a differentiated profile, including genuine null comparisons, rather than a single impairment label applied to an individual.

Historical primary source

Van der Plas EAA, Crone EA, van den Wildenberg WPM, Tranel D, Bechara A. Executive control deficits in substance-dependent individuals: A comparison of alcohol, cocaine, and methamphetamine, and of men and women. Journal of Clinical and Experimental Neuropsychology. 2009;31(6):706–719. doi:10.1080/13803390802484797.

A laboratory task and a report about daily life answer different questions. In a 2016 study, adults in remission from methamphetamine addiction reported more everyday executive difficulties than comparison adults and showed greater preference for immediate rewards. The findings challenge a blanket assumption that people with this history cannot recognize their difficulties.

Who participated?

Ellis and colleagues recruited 30 adults from addiction-treatment centers and 24 community comparison adults. The groups were matched on age, gender, ethnicity and estimated baseline intellectual functioning. Eligibility for the methamphetamine group required a history of at least 0.5 grams per day on at least five days a week for two years, with dependence established by structured interview.

Participants were in remission for at least two weeks and no more than 160 days. Positive urine screening at assessment was exclusionary. These criteria describe a selected remission sample; they do not establish a standardized prior dose, drug purity or exposure concentration at a particular earlier event.

What counted as an everyday problem?

The BRIEF-A questionnaire assessed difficulties with inhibition, shifting, emotional control, self-monitoring, initiating tasks, working memory, planning, task monitoring and organizing materials. A separate Barratt scale assessed several dimensions of impulsivity.

The remission group reported higher difficulties across the nine BRIEF-A clinical scales and six Barratt factors. The overall multivariate comparison was significant, followed by individual scale comparisons. These were ratings of perceived everyday functioning, not independently observed failures at work or home.

A group average being higher also does not mean every participant crossed a clinical threshold. Nor does it show that every executive function is impaired in every individual.

What did the monetary-choice task add?

Participants chose between immediate amounts from $1 to $99 and a delayed $100, with delays of seven, 30, 90, 180 or 365 days. The investigators modeled the rate at which delayed money lost subjective value. The remission group discounted delayed rewards more steeply.

The study recruited 54 people overall, but the reported discounting comparison has 38 degrees of freedom. The publication does not clearly reconcile that analysis denominator with the group totals in its table. It should therefore not be described as a complete 54-person objective-task comparison.

Does this establish accurate insight?

The coexistence of group-level subjective and objective differences supports taking participants’ reports seriously. It does not establish that a particular person’s self-assessment accurately matches their performance. That stronger claim would require individual-level agreement and external functional validation.

The observational design also cannot establish whether difficulties preceded substance use, resulted from it, or reflected depression, social circumstances or other influences. Exclusion of several comorbid conditions and medications narrows generalizability.

For case review, the useful distinction is between a person’s reported problems, measured task performance and independently documented functioning. This historical study supports assessing each, without treating either a questionnaire or a drug-use history as a determination of credibility, incapacity or driving impairment.

Historical primary source

Ellis C, Hoffman W, Jaehnert S, et al. Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction. Addictive Disorders & Their Treatment. 2016;15(1):1–5. doi:10.1097/ADT.0000000000000059. Original commentary on the supplied observational paper; no source figures reproduced.

A comparison between recently abstinent and long-abstinent people can suggest a possible recovery pattern. It cannot, by itself, show improvement within the same individuals. A 2009 methamphetamine study is useful evidence for that distinction.

Different people at different abstinence durations

Salo and colleagues compared 38 methamphetamine-dependent adults abstinent for three weeks to six months, 27 abstinent for more than one year, and 33 comparison adults. All 65 methamphetamine participants had been abstinent for at least three weeks.

The study pooled new behavioral observations from 21 methamphetamine participants with data from 44 participants already reported in two earlier papers. It therefore should not be counted as an entirely independent replication of those earlier datasets.

All participants completed the same computerized single-trial Stroop task. They named stimulus colors while the meaning of a word could interfere with the response. The principal outcome was reaction-time interference, measured in milliseconds, rather than a blood drug result or brain-scan measurement.

What were the group results?

Mean interference was 186 milliseconds in the recently abstinent group, 138 milliseconds in the long-abstinent group and 132 milliseconds in controls. In the main results, recent abstinence was associated with greater interference than controls (p = 0.002) and the long-abstinent group (p = 0.001).

The long-abstinent versus control comparison was not significant (p = 0.87). The group differences persisted when education and estimated premorbid ability were included as covariates.

The null long-abstinent comparison is important, but it is not a formal demonstration that the groups were equivalent. No universal normality or recovery threshold follows from a nonsignificant difference in one selected outcome.

Were errors also different?

All groups made more errors on conflicting than neutral trials—approximately 13% versus 2% across groups—but error rates did not differ significantly between the three groups. Reaction-time interference and error frequency therefore supported different statements.

The findings concerned a particular computerized task. They did not directly measure the ability to manage medication, maintain employment or drive safely, and the study did not establish a concentration-to-impairment relationship.

Why does cross-sectional design matter?

No participant’s cognitive ability was measured before methamphetamine use and then followed through both abstinence periods. The long-abstinent participants may have differed from recently abstinent participants before either group entered the study.

For example, people with better initial control might have been more likely to maintain prolonged abstinence. Matching selected background characteristics reduces some alternative explanations but cannot remove unmeasured differences. An association with abstinence duration is compatible with recovery without proving it.

This also means the paper does not conflict automatically with a study finding little change during the first month. The time windows, outcomes and study designs differ: comparing groups after a year is not the same as retesting the same people over several weeks.

How secure was abstinence verification?

Referring treatment programs conducted random urine screening, and the reported screens were negative. The authors nevertheless identified a lack of continuous objective verification of sustained status in the long-abstinent and control groups, such as ongoing urine screening or hair testing.

Negative intermittent samples cannot document every day of a long historical interval. The study’s abstinence categories should be reported with that qualification.

The defensible interpretation is a group-level association: selected long-abstinent participants performed similarly to controls on Stroop interference, while recently abstinent participants showed greater interference. Demonstrating within-person recovery requires longitudinal evidence.

Historical primary source

Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, Leamon MH. Drug Abstinence and Cognitive Control in Methamphetamine Dependent Individuals. Journal of Substance Abuse Treatment. 2009;37(3):292–297. doi:10.1016/j.jsat.2009.03.004. Original commentary on the supplied pooled cross-sectional study.

Response speed, accuracy and self-reported impulsivity measure different things. A 2023 methamphetamine fMRI study found differences in some of these outcomes and null results in others. Combining them into a single claim of “poor impulse control” would lose much of the evidence’s meaning.

The 39-person comparison

Zerekidze and colleagues recruited 21 methamphetamine-dependent adults and 21 comparison adults. Three participants in the methamphetamine group did not complete the protocol, leaving 18 and 21, respectively. The dependent group reported an average 8.3 days of abstinence, with a standard deviation of 6.4 days.

This was a cross-sectional human comparison during early abstinence. Reported prior consumption averaged 3.2 grams per week and was predominantly intranasal. Those self-reported histories were not standardized administered doses and did not establish the concentration present during testing.

Participants performed a manual color-word Stroop task during fMRI and completed the UPPS impulsivity questionnaire. The comparison group was younger on average and had more schooling, and the methamphetamine group reported substantial cannabis-use histories.

Response-time differences were not significant

Conflicting color-word trials slowed both groups. Mean interference time—the difference between conflicting and matching conditions—was 277.0 milliseconds in the methamphetamine group and 270.4 milliseconds in controls. Neither the overall group effect on response time nor the group-by-condition interaction was significant.

This is a substantive null result. It prevents describing the study as demonstrating greater Stroop slowing in the dependent group, even though other outcomes differed.

Accuracy and questionnaire results differed

The methamphetamine group had fewer correct responses overall and in the matching condition. The between-group accuracy difference for the conflicting condition alone was not significant. Both groups made more mistakes when the word and ink color conflicted.

On the questionnaire, urgency, lack of premeditation, lack of perseverance and the total impulsivity score were higher in the methamphetamine group. Sensation seeking did not differ significantly. A questionnaire difference therefore did not apply uniformly to every impulsivity dimension.

These results cannot establish how a particular participant would behave outside the scanner, and self-report scores are not interchangeable with response-time or accuracy measurements.

What did the imaging add?

The authors reported lower activation in fronto-cingulate, parietal and striatal regions, together with differences in sensory cortical regions. However, the broad maps used an uncorrected voxel threshold of p < 0.001. Some clusters survived family-wise error correction; the full set of displayed regions should not be described as having that stronger statistical support.

Within the methamphetamine group, left dorsolateral prefrontal and anterior midcingulate signals correlated with total correct responses. Exploratory visual-cortex signals did not correlate significantly with accuracy. Signals from these selected regions also did not correlate significantly with the UPPS total score.

Consequently, the sensory findings did not directly demonstrate that abnormal sensory processing caused the performance difference. Proposed explanations involving neuronal excitability or baseline activity were hypotheses, not mechanisms established by this experiment.

What should remain uncertain?

The sample was small and differed in education, age and cannabis history. Control-group sobriety was assessed by interview rather than toxicology screening. The observational design cannot distinguish pre-existing differences from effects of methamphetamine or other influences.

For interpretation, retain each outcome separately: response-time comparison null, selected accuracy comparisons significant, several questionnaire dimensions elevated, and imaging support varying by correction threshold. None of these findings validated an individual scan for intoxication, permanent injury or legal impairment.

Primary scientific source

Zerekidze A, Li M, Javaheripour N, Huff L, Weiss T, Walter M, Wagner G. Neural Correlates of Impaired Cognitive Control in Individuals with Methamphetamine Dependence: An fMRI Study. Brain Sciences. 2023;13:197. doi:10.3390/brainsci13020197. Original commentary on the supplied study.